Preclinical and clinical studies with various stem cells, their secretomes, and extracellular
vesicles (EVs) indicate their use as a promising strategy for the treatment of various …

Diseases of the central nervous system still remain among the most challenging pathologies
known to mankind, having no or limited therapeutic possibilities and a very pessimistic …

Spinal cord injury (SCI) has considerable impact on patient physical, mental, and financial
health. Secondary SCI is associated with inflammation, vascular destruction, and …

Cell-based technologies are used as a therapeutic strategy in spinal cord injury (SCI).
Mesenchymal stem cells (MSCs), which secrete various neurotrophic factors and cytokines …

During the past decade, mesenchymal stem cells (MSCs) have made their mark as a
potential weapon in regenerative medicine. Since their first isolation by Friedenstein in the …

Mesenchymal stem cells (MSCs) have been proposed as an alternative therapy to be
applied into several pathologies of the nervous system. These cells can be obtained from …

Spinal cord injury (SCI) is a traumatic lesion that can result in the loss of motor or sensory
neurons. Stem cell (SC)‑based therapies have been demonstrated to promote neuronal …

Spinal cord injury (SCI) represents one of the most complicated and heterogeneous
pathological processes of central nervous system (CNS) impairments, which is still beyond …

Mesenchymal Stem Cells or Marrow Stromal Cells (MSCs) have long been viewed as a
potent tool for regenerative cell therapy. MSCs are easily accessible from both healthy donor …

Spinal cord injury (SCI) constitutes an inestimable public health issue. The most crucial
phase in the pathophysiological process of SCI concerns the well-known secondary injury …